Fagron N.V. buy melinda
Start price
06.02.18
/
50%
€10.02
Target price
07.02.18
€11.40
Performance (%)
16.17%
End price
07.02.18
€11.64
Summary
This prediction ended on 07.02.18 with a price of €11.64. The prediction had a final performance of 16.17%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fagron N.V. | -2.667% | -2.667% | 18.251% | 41.382% |
| iShares Core DAX® | -5.868% | -2.496% | 2.292% | 50.129% |
| iShares Nasdaq 100 | 1.660% | 3.513% | 13.191% | 88.484% |
| iShares Nikkei 225® | -6.126% | 2.136% | 27.665% | 53.973% |
| iShares S&P 500 | 0.504% | 2.045% | 9.817% | 60.027% |
Comments by melinda for this prediction
In the thread Fagron N.V. diskutieren
Pharmazeutische SecteurProduits Agenda 07/02 Ergebnisse Veröffentlichung
Die geographische Verteilung des Umsatzes sieht wie folgt aus: Belgien (8%), Europa (51,5%), Lateinamerika (21,6%), USA (18,1%) und sonstiges (0,8%).
Anzahl der Mitarbeiter: 1.991 Personen.